Immunosuppressive Potential and Side Effects of Everolimus
Authors:
Open Access
- 27 August 2012
- journal article
- letter
- Published by Elsevier in American Journal of Transplantation
- Vol. 12 (9) , 2563-2564
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Does Everolimus Increase Donor-Specific HLA Antibodies in Kidney Transplant Recipients?American Journal of Transplantation, 2012
- Long-term Impact of Subclinical Inflammation Diagnosed by Protocol Biopsy One Year After Renal TransplantationAmerican Journal of Transplantation, 2011
- Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four-Year Results of the Postconcept StudyAmerican Journal of Transplantation, 2011
- How to Use mTOR Inhibitors? The Search Goes OnAmerican Journal of Transplantation, 2011
- Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trialThe Lancet, 2011